ADORA2B
Adenosine receptor A2b
Also known as: AA2BR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P29275
- Gene
- ADORA2B
- Ensembl
- ENSG00000170425
- Chromosome
- 17
- Canonical length
- 332 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes an adenosine receptor that is a member of the G protein-coupled receptor superfamily. This integral membrane protein stimulates adenylate cyclase activity in the presence of adenosine. This protein also interacts with netrin-1, which is involved in axon elongation. The gene is located near the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
332 residues, UniProt reviewed canonical sequence.
>P29275|ADORA2B
1 MLLETQDALY VALELVIAAL SVAGNVLVCA AVGTANTLQT PTNYFLVSLA AADVAVGLFA
61 IPFAITISLG FCTDFYGCLF LACFVLVLTQ SSIFSLLAVA VDRYLAICVP LRYKSLVTGT
121 RARGVIAVLW VLAFGIGLTP FLGWNSKDSA TNNCTEPWDG TTNESCCLVK CLFENVVPMS
181 YMVYFNFFGC VLPPLLIMLV IYIKIFLVAC RQLQRTELMD HSRTTLQREI HAAKSLAMIV
241 GIFALCWLPV HAVNCVTLFQ PAQGKNKPKW AMNMAILLSH ANSVVNPIVY AYRNRDFRYT
301 FHKIISRYLL CQADVKSGNG QAGVQPALGV GLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADORA2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- urinary bladder: 16 nTPM
- cerebral cortex: 13 nTPM
- choroid plexus: 11 nTPM
- esophagus: 10 nTPM
- skin: 9.7 nTPM
- colon: 9.6 nTPM
Single-cell type
- basal keratinocytes: 82 nCPM
- retinal pigment epithelial cells: 60 nCPM
- suprabasal keratinocytes: 57 nCPM
- esophageal basal cells: 47 nCPM
- conjunctival goblet cells: 46 nCPM
- bergmann glia: 42 nCPM
Immune cell
- basophil: 17 nTPM
- myeloid DC: 11 nTPM
- intermediate monocyte: 5.9 nTPM
- classical monocyte: 5 nTPM
- eosinophil: 3.4 nTPM
- non-classical monocyte: 3.2 nTPM
Brain region
- cerebral cortex: 12 nTPM
- basal ganglia: 9.5 nTPM
- hippocampal formation: 8.7 nTPM
- choroid plexus: 8.6 nTPM
- thalamus: 6.9 nTPM
- white matter: 6.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.49
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.06
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activation of adenylate cyclase activity
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- cGMP-mediated signaling
- G protein-coupled receptor signaling pathway
- mast cell degranulation
- positive regulation of cGMP-mediated signaling
- positive regulation of chemokine production
- positive regulation of interleukin-6 production
- positive regulation of mast cell degranulation
- positive regulation of vascular endothelial growth factor production
- presynaptic modulation of chemical synaptic transmission
- relaxation of vascular associated smooth muscle
- vasodilation
- positive regulation of chronic inflammatory response to non-antigenic stimulus
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADORA2B as an antibody target. Whether an autoantibody or antibody against ADORA2B could matter depends on whether native ADORA2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADORA2B is annotated at the cell surface, where native ADORA2B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADORA2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...